Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:08 PM
Ignite Modification Date:
2025-12-24 @ 9:08 PM
NCT ID:
NCT00566904
Eligibility Criteria:
Inclusion Criteria:
* In good general health
* Postherpetic neuralgia, defined as pain persisting more than 4 months after onset of herpes zoster outbreak
* Willing to use effective forms of contraception for the duration of the study
Exclusion Criteria:
* Known lidocaine sensitivity or allergy
* Inability to discontinue use of any nonstudy lidocaine-containing products for the duration of the study
* Known hypersensitivity to aspirin
* Open herpes zoster blisters
* Known sensitivity or allergy to an amide-type local anesthetic agent
* Existing conditions that make participation unsafe
* Pregnant
* Immunocompromised (e.g., HIV infected)
* Herpes zoster in any dermatome (area of skin innervated by a specific sensory nerve) affecting the face or scalp
* Affected skin area is greater than 420 square cm
* Affected area includes skin breakdown or nonintact skin
* Affected area consists of more than one contiguous area
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00566904
Study Brief:
Protocol Section:
NCT00566904